On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia.
Lo Coco
F
F
Diverio
D
D
Avvisati
G
G
Mandelli
F
F
Biondi
A
A
Pelicci
P G
PG
D014408:Biomarkers, Tumor; D002454:Cell Differentiation / Q000187:drug effects; D015321:Gene Rearrangement; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000473:pathology / Q000628:therapy*; D009363:Neoplasm Proteins / Q000187:drug effects / Q000235:genetics; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000473:pathology; D018168:Receptors, Retinoic Acid / Q000187:drug effects / Q000235:genetics; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin / Q000494:pharmacology* / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D007155:Immunologic Factors; D009363:Neoplasm Proteins; C000607071:RARA protein, human; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin